CD&R and McKesson to Acquire Option Care Health for $5.8B
Clayton, Dubilier & Rice and McKesson agree to acquire Option Care Health for $32.05 per share in cash, valuing the infusion provider at $5.8 billion.
Clayton, Dubilier & Rice and McKesson agree to acquire Option Care Health for $32.05 per share in cash, valuing the infusion provider at $5.8 billion.
Mistras Group agrees to an $866M all-cash buyout by H.I.G. Capital at $20.35 per share, featuring a 40-day go-shop window and a $49.9M reverse termination fee.
Lantheus Holdings (LNTH) is weighing a roughly $7 billion takeover bid from PE-backed Curium Pharma. Shares jumped 9% on the report.